Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV Infections in Immunocompromised Adults

Condition:   HSV Infection Interventions:   Drug: Pritelivir;   Drug: Foscarnet Injection [Foscavir] Sponsors:   AiCuris Anti-infective Cures GmbH;   Medpace, Inc. Not yet recruiting - verified March 2017

Source: ClinicalTrials.gov - March 3, 2017 Category: Research Source Type: clinical trials